UK markets close in 1 hour 5 minutes

ALK-Abelló A/S (ALK-B.CO)

Copenhagen - Copenhagen Real-time price. Currency in DKK
Add to watchlist
126.10+4.60 (+3.79%)
As of 04:24PM CEST. Market open.

ALK-Abelló A/S

Boge Alle 6-8
Horsholm 2970
Denmark
45 45 74 75 76
https://www.alk.net

Sector(s)Healthcare
IndustryBiotechnology
Full-time employees2,587

Key executives

NameTitlePayExercisedYear born
Mr. Carsten HellmannPres, CEO & Member of Management Board14.45MN/A1964
Mr. Søren JelertGroup CFO, Exec. VP & Member of Management Board6.14MN/A1972
Mr. Henrik JacobiExec. VP of R&D and Member of Board of Management5.37MN/A1965
Mr. Søren Daniel NiegelExec. VP of Commercial Operations & Member of Management Board5.34MN/A1971
Ms. Katja Barnkob ThalundProject Director of Global CMC Devel. & Employee-elected Director300kN/A1969
Mr. Per PlotnikofVP of Corp. Communications, Investor Relations & Strategic Planning and Head of IRN/AN/AN/A
Prof. Hendrik Kees Kam Nolte M.D., Ph.D.Sr. VP of Research & Devel. - North America and International MarketsN/AN/AN/A
Mr. Christian G. HoughtonHead of Product SupplyN/AN/AN/A
Mr. Miles GuralnickPres of ALK Abelló Source Materials IncN/AN/AN/A
Amounts are as of 31 December 2021, and compensation values are for the last fiscal year ending on that date. Pay includes salary, bonuses, etc. Exercised is the value of options exercised during the fiscal year. Currency in DKK.

Description

ALK-Abelló A/S operates as an allergy solutions company in Europe, North America, and internationally. The company offers allergy immunotherapy products in the form of injections, sublingual drops, and tablets for the treatment of various allergies, including house dust mite, grass, tree, ragweed, and Japanese cedar. It also provides adrenaline auto-injectors for the treatment of severe allergic reactions; and manufactures products used in the diagnosis of allergies. The company offers GRAZAX, RAGWITEK, RAGWIZAX, MITICURE, ODACTRA, CEDARCURE, and ITULAZAX for the treatment of allergic rhinitis; and ACARIZAX for treating allergic rhinitis and allergic asthma. ALK-Abelló A/S was founded in 1923 and is headquartered in Hørsholm, Denmark.

Corporate governance

ALK-Abelló A/S’s ISS governance QualityScore as of 1 October 2022 is 3. The pillar scores are Audit: 1; Board: 4; Shareholder rights: 9; Compensation: 2.

Corporate governance scores courtesy of Institutional Shareholder Services (ISS). Scores indicate decile rank relative to index or region. A decile score of 1 indicates lower governance risk, while 10 indicates higher governance risk.